Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 28.22% vs 12.27% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 91.74% vs 12.32% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 85.35% vs 4.82% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 8.55% vs -20.63% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Bliss GVS Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 9.73% vs 11.12% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 28.22% vs 12.27% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 4.29% vs 40.81% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 91.74% vs 12.32% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 5.47% vs 71.94% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 85.35% vs 4.82% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 468.97% vs -71.14% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 8.55% vs -20.63% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025